文献速递关节外科创伤骨科

抗内突笼与多孔钽加强块联合治疗严重髋臼缺损:平均随访6.6年的临床与影像学结果

Treatment of Severe Acetabular Defects With an Antiprotrusio Cage and Trabecular Metal Augments - Clinical and Radiographic Results After a Mean Follow-Up of 6.6 Years.
PubMed 文献 · J Arthroplasty · 2023-06-02

该研究纳入2008至2013年间100例Paprosky 2型和3型髋臼缺损(含骨盆不连续)行髋臼杯翻修并采用笼-加强块组合的连续患者,59例获得随访。主要终点为笼-加强块组合的取出,平均随访6.2年无取出生存率为91.9%,6例取出均因假体周围感染;总体无翻修植入物生存率为85.7%。作者认为该组合是治疗大髋臼缺损有前景的技术,但需特别关注假体周围感染和不稳定风险。

要点

  • Paprosky 2、3型髋臼缺损(含骨盆不连续)采用抗内突笼联合多孔钽加强块,平均随访6.2年无取出生存率91.9%。
  • 6例取出均因假体周围感染;另有6例早期假体周围感染经清创、冲洗和保留植入物成功治疗。
  • 总体无翻修植入物生存率85.7%,另因不稳定行6例内衬翻修;1例影像学松动但无需治疗。

核心结论

  • 抗内突笼联合多孔钽加强块是治疗大髋臼缺损有前景的技术。
  • 大骨与软组织缺损导致的假体周围感染和不稳定主要风险需特别关注。

研究设计与样本

  • 2008至2013年间连续纳入100例Paprosky 2型和3型缺损(含骨盆不连续)行髋臼杯翻修并采用笼-加强块组合的患者,59例获得随访。
  • 主要终点为笼-加强块组合取出,次要终点为任何原因的髋臼杯翻修,并评估影像学与功能结局(WOMAC、Harris髋关节评分),采用Kaplan-Meier分析植入物生存率,显著性水平设为P<.05。

主要发现

  • 平均随访6.2年(范围0至12.8年),笼-加强块组合无取出生存率为91.9%。
  • 全部6例取出均因假体周围感染。
  • 总体无翻修植入物生存率为85.7%,包括另因不稳定行6例内衬翻修。
  • 另发生6例早期假体周围感染,经清创、冲洗和保留植入物成功治疗。
  • 观察到1例影像学松动但无需治疗。

局限性

  • 100例连续患者中仅59例获得随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Large acetabular bone defects present a serious challenge in revision total hip arthroplasty. The off-label use of antiprotrusio cages in combination with tantalum augments is a promising treatment option in these difficult situations. METHODS: Between 2008 and 2013, 100 consecutive patients underwent acetabular cup revision with a cage-augment combination in Paprosky 2 and 3 defect types (including pelvic discontinuities). There were 59 patients available for follow-up. The primary endpoint was the explantation of the cage-and-augment construct. The secondary endpoint was acetabular cup revision for any reason. Also, radiographic and functional outcomes (Western Ontario and McMaster Universities Osteoarthritis Index, Harris Hip Score) were evaluated. Implant survival rates were determined using a Kaplan-Meier analysis. The significance level was set at P < .05. RESULTS: Explantation-free survivorship of the "Cage-and-Augment" system was 91.9% after a mean follow-up of 6.2 years (range, 0 to 12.8). All 6 explantations were due to periprosthetic joint infection (PJI). The overall revision-free implant survival rate was 85.7%, including 6 additional liner revisions due to instability. In addition, 6 early PJI occurred, which were successfully treated with debridement, irrigation, and implant retention. We did observe one patient who had radiographic loosening of the construct without necessity for treatment. CONCLUSION: The combination of an antiprotrusio cage with tantalum augments is a promising technique in treating large acetabular defects. A major risk of PJI and instability due to large bone and soft tissue defects needs special attention.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Bellova P, Reich MC, Grothe T, et al. Treatment of Severe Acetabular Defects With an Antiprotrusio Cage and Trabecular Metal Augments - Clinical and Radiographic Results After a Mean Follow-Up of 6.6 Years. J Arthroplasty. 2023. PMID: 37271233. doi:10.1016/j.arth.2023.05.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。